That is a small dose of retacrit. Epogen and its related products such as retacrit can trigger the growth of solid tumors by studies; however, the risk is low compared with the benefits, especially at low doses. For many years, oncologists have used these products for combating anemia in cancer patients. For patients with advanced kidney disease, its use is a must for avoiding blood transfusion.
Answered 5/3/2022
0 views
6 doctors weighed in across 2 answers
A doctor has provided 1 answer
2 doctors weighed in across 2 answers
5 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question